Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Celldex Therapeutics Inc.

TRADE

NASDAQ: CLDXHealthcare / Biotechnology / USA
0.5100.00Vol 963 7861Y Perf -78.38%
Jul 20th, 2018 16:00
BID0.51 ASK0.51
Open0.51 Previous Close0.51
Pre-Market- After-Trading0.52
 - -%  0.01 1.96%
Target Price
1.58 
Analyst Rating
Moderate Buy 2.33
Potencial %
209.80 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★★     58.13
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)73 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.08 
Earnings Date
14th Aug 2018

Today's Price Range

0.510.53

 

52wk Range

0.483.26

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-8.93%
3 Months
-27.14%
6 Months
-81.52%
1 Year
-78.38%
3 Years
-98.00%
5 Years
-97.58%

Quotes

Name / TickerPriceChg.Chg.%
CLDX0.510.00000.00
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.30
Current Ratio 5.50
Long Term Debt to Total Capital -
Total Debt to Equity 0.03
Interest Coverage -
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-551.40
EBITDA Margin-518.90
Pre-tax Profit Margin-2 082.50
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.56
PS Ratios 6.52
Price to Cash Flow 8.30
Price to Free Cash Flow -1.00
Cash Flow Per Share -0.70
Price to Tangible Book0.87
Book Value per Share0.94
Enterprise Value (in ths.)-48 598
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-44.62
ROE last 12 Months -84.06
Return on Assets (5Y Avg) -38.43
ROA last 12 Months -58.19
Return on Capital (5Y Avg) -43.21
ROC last 12 Months -92.64
Return on invested Capital Q -63.78
Return on invested Capital Y-36.13
Assets Turnover0.00
Receivables Turnover3.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)11 448
Revenue per Share 0.08
Revenue Growth 3 Years 31.65
Revenue Growth 5 Years 14.37
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.17-0.19-11.76
Q04 2017-0.23-0.1726.09
Q03 2017-0.24-0.1441.67
Q02 2017-0.25-0.238.00
Q01 2017-0.28-0.280.00
Q04 2016-0.34-0.3011.76
Q03 2016-0.32-0.299.38
Q02 2016-0.33-0.323.03
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.1233.33Positive
9/2018 QR-0.1147.62Positive
12/2018 FY-0.6023.08Positive
12/2019 FY-0.5622.22Positive
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.14
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume963 786
Shares Outstanding (in ths.)143 390
Trades Count2 954
Dollar Volume481 234
Avg. Volume2 584 737
Avg. Weekly Volume1 134 769
Avg. Monthly Volume2 786 727
Avg. Quarterly Volume3 071 034

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

72%28%

Bearish Bullish

78%22%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (25.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
3 (75.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.50
Strong Buy
1.50

There are no comments yet.

News

x